Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001736361-20-000002
Filing Date
2020-01-28
Accepted
2020-01-28 14:42:54
Documents
1
Effectiveness Date
2020-01-28
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6877
  Complete submission text file 0001736361-20-000002.txt   7947
Mailing Address C/O LABCENTRAL 700 MAIN STREET CAMBRIDGE MA 02139
Business Address C/O LABCENTRAL 700 MAIN STREET CAMBRIDGE MA 02139 617-529-0160
Acworth Pharmaceuticals, Inc. (Filer) CIK: 0001736361 (see all company filings)

EIN.: 814610456 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-359109 | Film No.: 20553730